Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06993558 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Analysis of Safety and Tissue Interaction of Injectable Biosmulators

Study acronym: Biostimulation
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 15, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Start date: Mar 22, 2025 to Jul 31, 2025v2 Show 8 more changesShow less
    • Primary completion date: Mar 22, 2026 to Jul 31, 2026
    • Study completion date: Sep 22, 2026 to Sep 15, 2027
    • Interventions: Calcium Hydroxyapatite (Procedure), Poly-L-Lactic Acid (Sculptra) injection (Procedure), Radiofrequency Microneedling (Procedure) to Calcium Hydroxyapatite (Procedure), Poly-L-Lactic Acid (Sculptra) injection (Procedure)
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description shortened, about 18 words
    • Study arms: 3 to 2
    • Eligibility criteria shortened, about 1 word
    • Study title shortened, about 2 words
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to analyse tissue changes in the pre-auricular region after injectable (Poly-L-Lactic-Acid/Calcium-Hydroxylapatit) biostimulatory interventions in healthy volunteers. The main questions it aims to answer are: How is the Safety Profile of injectable Biostimulatory Treatments? How are the Tissue Interactions after injectable Biostiomulatory Treatments? Participants will: * Recieve one of 2 possible biostumulatory treatments (PLLA/CAHA/ * Attend 4 follow-up appointments after treatment for checkups, surveillance and examinations.
Trial Details
NCT Number NCT06993558
Lead Sponsor Universitätsklinikum Hamburg-Eppendorf
Conditions
(from sponsor)
This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov